Survey on the Burden of surgery and Patient Preferences in treatment for Rectal Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030260218

Enrollment

200

Registered

2026-06-12

Start date

2026-06-24

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: [Patients] Patients diagnosed with rectal cancer who have undergone surgery for rectal cancer. Patients aged 18 years or older at the time of consent and residing in Japan. Patients who have agreed to participate in the study. Patients who possess devices and an environment that allow access to the internet in Japanese to respond to the study questionnaire. [Physicians] Physicians with experience in treating rectal cancer at medical institutions in Japan (including surgical treatment, chemotherapy, radiotherapy, or perioperative management). Physicians who understand the purpose and methodology of the study and have agreed to participate.

Exclusion criteria

Exclusion criteria: [Patients] Patients who are themselves employed by GlaxoSmithKline K.K. or 3H Medisolution Co., Ltd., or have family members who are employed by these companies. [Physicians] None.

Design outcomes

Primary

Measure	Time frame
Assesment of surgical burden and treatment satisfaction Quantification of preferences in treatment for rectal cancer	—

Secondary

Measure	Time frame
Discrepancies between patient and physician perceptions Exploration of factors influencing preferences in treatment for rectal cancer	—

Contacts

Public ContactKingo Kanda

GlaxoSmithKline K.K.

jp.gskjrct@gsk.com+81-120-561-007

Outcome results